JAX strives to advance rare disease research and treatment options

For the past six years, the JAX Rare Disease Translational Center has worked with dozens of rare disease foundations to create custom mouse models that represent rare medical conditions, the majority of which present in young children.

In May 2022, JAX appointed Cathleen (Cat) Lutz, Ph.D., M.B.A. as Vice President of the Rare Disease Translational Center, marking an important step forward in its commitment to rare disease research. The expansion positions the Center to play an integral role throughout the entire rare disease odyssey, from diagnosis to research to drug development. The Center also collaborates closely with biotech and pharmaceutical companies to accelerate the path to drug discovery for these debilitating conditions. By taking a more holistic approach, the Center will make a significant impact on the experience of those living with rare diseases. Read more

Related Posts

Maine’s first mobile biolab starts tour of rural schools in Fort Kent

FORT KENT, Maine — Fort Kent middle schoolers are the state’s first students to learn at the newly unveiled Maine Mobile Biolab, a 50-foot,...

12 March 2024

UMaine Augusta’s $1.75M medical lab training facility doubles student capacity

Anew medical lab training facility on the campus of University of Maine Augusta is nearly six times larger than an off-campus space...

21 February 2024

UNE receives grant to research state-threatened animal

The University of New England has received a grant from the Maine Department of Inland Fisheries and Wildlife to study one...

12 February 2024